Back to All Events

Strategic, Regulatory, & IP Considerations For Emerging Life Sciences Companies In The US & Canada

Bringing an emerging life sciences company from concept to marketplace means developing a clear strategy to deal with regulatory and patent concerns. Early decisions made in product development can shape later regulatory requirements and enforcement risks, and patent strategic issues, both pre- and post-market.

Click here to Register for the Webinar

Later Event: February 1
Pre-CAAP® Webinar